EVOFEM BIOSCIENCES INC (EVFM) Stock Price, Quote, News and Overview
NASDAQ:EVFM - Nasdaq - US30048L2034 - Common Stock - Currency: USD
EVFM Quote, Performance and Key Statistics
0.4782
-0.15 (-23.37%)
The current stock price of EVFM is 0.4782 USD. In the past month the price decreased by -58.42%. In the past year, price decreased by -95.52%.
EVFM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 59.86 | 780.78B | ||
| JNJ | JOHNSON & JOHNSON | 15.53 | 375.64B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 20.07 | 307.32B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.75 | 225.73B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 19.47 | 224.59B | ||
| MRK | MERCK & CO. INC. | 10.68 | 209.31B | ||
| PFE | PFIZER INC | 7.54 | 137.25B | ||
| SNY | SANOFI-ADR | 14.4 | 135.72B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.89 | 102.91B | ||
| GSK | GSK PLC-SPON ADR | 7.16 | 79.05B | ||
| ZTS | ZOETIS INC | 26.59 | 70.23B | ||
| HLN | HALEON PLC-ADR | 22.29 | 48.25B |
Related stock screener links
About EVFM
Company Profile
Evofem Biosciences Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in San Diego, California and currently employs 119 full-time employees. The company went IPO on 2014-11-20. Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. The company is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). Its product, Phexxi vaginal gel, is a hormone-free, woman-controlled, on-demand prescription contraceptive gel for women. Its lead clinical program is evaluating Phexxi (using the investigational name EVO100) for the prevention of chlamydia and gonorrhea in women. EVO200 vaginal gel (EVO200), its investigational candidate for the reduction of recurrent bacterial vaginosis (BV), uses the same vaginal potential of hydrogen (pH) modulator platform as Phexxi. The company also focuses on developing Multipurpose Prevention Technology (MPT) vaginal gel for indications, including the prevention of human immunodeficiency virus (HIV) in women through Orion Biotechnology Canada Ltd.
Company Info
EVOFEM BIOSCIENCES INC
12400 High Bluff Dr Ste 600
San Diego CALIFORNIA 92130 US
CEO: Saundra Pelletier
Employees: 119
Phone: 18585501900.0
EVOFEM BIOSCIENCES INC / EVFM FAQ
What is the stock price of EVOFEM BIOSCIENCES INC today?
The current stock price of EVFM is 0.4782 USD. The price decreased by -23.37% in the last trading session.
What is the ticker symbol for EVOFEM BIOSCIENCES INC stock?
The exchange symbol of EVOFEM BIOSCIENCES INC is EVFM and it is listed on the Nasdaq exchange.
On which exchange is EVFM stock listed?
EVFM stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for EVOFEM BIOSCIENCES INC stock?
11 analysts have analysed EVFM and the average price target is 11.27 USD. This implies a price increase of 2256.96% is expected in the next year compared to the current price of 0.4782. Check the EVOFEM BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is EVOFEM BIOSCIENCES INC worth?
EVOFEM BIOSCIENCES INC (EVFM) has a market capitalization of 20.18M USD. This makes EVFM a Nano Cap stock.
How many employees does EVOFEM BIOSCIENCES INC have?
EVOFEM BIOSCIENCES INC (EVFM) currently has 119 employees.
What are the support and resistance levels for EVOFEM BIOSCIENCES INC (EVFM) stock?
EVOFEM BIOSCIENCES INC (EVFM) has a resistance level at 0.75. Check the full technical report for a detailed analysis of EVFM support and resistance levels.
Is EVOFEM BIOSCIENCES INC (EVFM) expected to grow?
The Revenue of EVOFEM BIOSCIENCES INC (EVFM) is expected to grow by 295.01% in the next year. Check the estimates tab for more information on the EVFM EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy EVOFEM BIOSCIENCES INC (EVFM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EVFM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EVFM, evaluating the profitability, health, valuation and growth aspects
- EVOFEM BIOSCIENCES INC (EVFM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- EVOFEM BIOSCIENCES INC (EVFM) Sales and EPS estimates to see what analysts future expectations are.
- EVOFEM BIOSCIENCES INC (EVFM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- EVOFEM BIOSCIENCES INC (EVFM) Insider and Institutional Ownership to learn about the owners and their transactions.
- EVOFEM BIOSCIENCES INC (EVFM) Stock Chart to make your own analysis
- EVOFEM BIOSCIENCES INC (EVFM) Latest news and press-releases to stay up to date.
Does EVOFEM BIOSCIENCES INC (EVFM) stock pay dividends?
EVFM does not pay a dividend.
When does EVOFEM BIOSCIENCES INC (EVFM) report earnings?
EVOFEM BIOSCIENCES INC (EVFM) will report earnings on 2022-11-14.
What is the Price/Earnings (PE) ratio of EVOFEM BIOSCIENCES INC (EVFM)?
EVOFEM BIOSCIENCES INC (EVFM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-15.3).
What is the Short Interest ratio of EVOFEM BIOSCIENCES INC (EVFM) stock?
The outstanding short interest for EVOFEM BIOSCIENCES INC (EVFM) is 0.06% of its float. Check the ownership tab for more information on the EVFM short interest.
EVFM Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to EVFM. When comparing the yearly performance of all stocks, EVFM is a bad performer in the overall market: 98.86% of all stocks are doing better.
EVFM Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to EVFM. Both the profitability and financial health of EVFM have multiple concerns.
EVFM Financial Highlights
Over the last trailing twelve months EVFM reported a non-GAAP Earnings per Share(EPS) of -15.3. The EPS decreased by -553.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -1676.29% | ||
| ROA | -552.28% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
EVFM Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to EVFM. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 57.85% and a revenue growth 295.01% for EVFM